text.skipToContent text.skipToNavigation

Shareholder Structure

As a consequence of the stock split and the increase of the individual par value of the company's shares, Sartorius Stedim Biotech S.A.’s issued capital amounted to €18.4 million as of December 31, 2018, and was divided into 92,180,190 shares, each with a calculated par value of €0.20. As some of the shares convey double voting rights, there were a total of 161,024,614 voting rights as of the reporting date.

As of December 31, 2018, Sartorius AG holds 74.3% of the share capital and 85.0% of the outstanding voting rights. The remaining 25.7% of the shares are in free float; corresponding to 15.0% of the outstanding voting rights.

 

S1.jpg